Beilstein J. Org. Chem.2018,14, 2646–2650, doi:10.3762/bjoc.14.242
latent TB. Herein we report the design and synthesis of the first phenothiazine–siderophoreconjugate. A convergent synthetic route was developed whereby the functionalised phenothiazine component was prepared in four steps and the siderophore component also prepared in four steps. In M. smegmatis the
antibacterial agents.
Keywords: NDH-2; phenothiazine; siderophore; siderophore–antibiotic; siderophoreconjugate; Introduction
One of the biggest challenges facing the modern society is antibiotic resistance and the prospect of current antibiotics becoming near redundant against previously treatable
achieved with beta-lactam-based siderophore conjugates targeting membrane associated penicillin binding proteins (PBPs) [7]. Cefiderocol (S-649266) is a beta-lactam–siderophoreconjugate currently in phase III clinical trials which demonstrates enhanced potency against Gram-negative bacteria including
PDF
Graphical Abstract
Figure 1:
NDH-2 is a validated target for 1 with an MIC of 1.1 µg/mL against M. tuberculosis.